NCT03738410 An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
| NCT ID | NCT03738410 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | HIV/AIDS |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-05-02 |
| Primary Completion | 2026-06-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2022-05-02 with a primary completion date of 2026-06-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is: 1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication) and address individual barriers to HIV care (like stigma, medical mistrust and resilience). 2. The intervention will also include patient navigation and motivational interviewing 2\) Investigators also want to see if the mHealth system is feasible, easily accepted and if it will impact patient health in a positive way.
Eligibility Criteria
Inclusion Criteria: * Confirmed HIV diagnosis as per the clinic standard * Female \>= 18 years old at enrollment * Currently active or recently returned into care or newly enrolled * With two or more previously scheduled visits (12 months prior to study enrollment * in the 12 months prior to enrollment: * missed one or more visits or * viral load detectable (\>20 mL) or * not taking prescribed HIV anti-retroviral medications Exclusion Criteria: * men * women who are cognitively impaired or are not able to consent for themselves * non-working cell phone * adolescents \< 18 years old at enrollment
Contact & Investigator
Lunthita M Duthely, Ed.D.
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT03738410 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying HIV/AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03738410 currently recruiting?
Yes, NCT03738410 is actively recruiting participants. Contact the research team at lduthely@med.miami.edu for enrollment information.
Where is the NCT03738410 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT03738410 clinical trial?
NCT03738410 is sponsored by University of Miami. The principal investigator is Lunthita M Duthely, Ed.D. at University of Miami. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.